Ranbaxy has said it received a
notice from the US Food and Drugs
Administration (FDA) regarding
possible violations.
The notice referred to the
company’s Toansa active-pharmaceutical-
ingredients
manufacturing plant in Punjab, the
Wall Street Journal reported.
The company was assessing the
observations and would respond to
the FDA, the publication said.
To read more CLICK HERE.The above article was sent to subscribers in Pharmacy Daily's issue from 16 Jan 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Jan 14
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.